• Login
    View Item 
    •   HPS Repository Home
    • Embryo Project Encyclopedia
    • Embryo Project Articles
    • View Item
    •   HPS Repository Home
    • Embryo Project Encyclopedia
    • Embryo Project Articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus with Zidovudine Treatment

    Thumbnail
    View/Open
    LitMIHIVTransmissionAZTCVF.xhtml (19.18Kb)
    Author
    Florez, Chase V.
    Metadata
    Show full item record
    Abstract
    In 1994, Edward M. Connor and colleagues published “Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment.” Their study summarized how to reduce the transfer of human immunodeficiency virus, or HIV, from pregnant women to their fetuses with Zidovudine, otherwise known as AZT. HIV is a virus that weakens the immune system by destroying white blood cells, a part of the body’s immune system. Fifteen to forty percent of infants born to HIV-positive mothers become infected during fetal development, labor and delivery, or breast-feeding. From April 1991 to December 1993, Connor and his colleagues researched HIV-positive pregnant women who took AZT, a drug that treats but does not cure an HIV infection. In their article, Conner and colleagues showed that AZT decreased the maternal-infant transmission of HIV and helped decrease infant mortality due to the viral infection.
    URI
    https://hpsrepository.asu.edu/handle/10776/13141
    Collections
    • Embryo Project Articles

    Browse

    All of HPS RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister
    DSpace software Copyright © 2015  Duraspace
    Contact Us | Send Feedback